Welcome to the Begell House Online Submission System!
|
|
|||
| Editor-in-Chief: | Benjamin Bonavida |
| Editorial Board |
| Author Instructions |
| Register for Journal Updates |
| NIH Public Access policy |
Aims and Scope
The primary objective of "Critical ReviewsTM in Oncogenesis" is the advancement and dissemination of scientific and clinical knowledge relating to the molecular basis of Oncogenesis for both its originality and scientific merit. CRO is dedicated to publishing timely critical reviews on topics of current interests with emphasis in basic, molecular and translational applications in the field of Oncogenesis. Further emphasis will also be placed on the role Oncogenesis in the development of cancer and malignancies as well as the role of cancer stem cells and their oncogenic potential. Reviews will also consider the role of oncogenes as diagnostics and therapeutic targets. This journal will publish special thematic issues on selected topics such as described above and employing many multidisciplinary approaches. Articles are by invitation only.
In contrast to reviews in several other publications, CRO will be focused on its specific and unique thematic approach for each issue that is contributed by various experts in and, often, an invited Guest Editor will be appointed for a particular issue. This multidisciplinary approach for a specific topic in Oncogenesis will distinguish CRO from many other journals whereby individual reviews are published. We believe that the new CRO objective will lead to a wide readership and will be used as an essential reference for research scientists, clinicians, students, and health professionals. The new Aims and Scope of CRO are designed to interest a wide readership and make it a reference standard in Oncogenesis.
In contrast to reviews in several other publications, CRO will be focused on its specific and unique thematic approach for each issue that is contributed by various experts in and, often, an invited Guest Editor will be appointed for a particular issue. This multidisciplinary approach for a specific topic in Oncogenesis will distinguish CRO from many other journals whereby individual reviews are published. We believe that the new CRO objective will lead to a wide readership and will be used as an essential reference for research scientists, clinicians, students, and health professionals. The new Aims and Scope of CRO are designed to interest a wide readership and make it a reference standard in Oncogenesis.
ISSN: 0893-9675
ISSN: 2162-6448
Issues per year: 4 | |
| For Online Access | |

